Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    R1 RCM Inc (RCM) Insider Trading Activity

    Healthcare • Health Information Services • 29,400 employees

    R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah.

    Total Value

    -$535,466,385.24

    Total Shares

    -35,248,275

    Average Trade Value

    -$21,418,655.41

    Most Active Insider

    Tcp Asc Achi Series Lllp

    Total Activity: $436,292,077

    Largest Single Transaction

    $436,292,077

    by Tcp Asc Achi Series Lllp on Nov 19, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Nov 19, 2024 62,453 $893,078 0 Sale to Issuer
    Principal Accounting Officer
    Nov 19, 2024 6,767 $0 33,522 (+20.2%) Grant
    Principal Accounting Officer
    Nov 19, 2024 33,522 $479,365 0 Sale to Issuer
    Nov 19, 2024 22,241 $318,046 0 Sale to Issuer
    Chief Commercial Officer
    Nov 19, 2024 306,621 $0 356,975 (+85.9%) Grant
    Director, 10% Owner
    Nov 19, 2024 30,548,388 $436,292,077 154,837,588 (-19.7%) Sale
    Nov 19, 2024 61,041 $872,886 0 Sale to Issuer
    Nov 19, 2024 98,238 $0 3,485,379 (+2.8%) Grant
    Nov 19, 2024 33,014 $472,100 0 Sale to Issuer
    Nov 19, 2024 3,485,379 $49,840,920 0 Sale to Issuer
    Chief Financial Officer
    Nov 19, 2024 355,006 $0 423,479 (+83.8%) Grant
    Chief Financial Officer
    Nov 19, 2024 423,479 $6,055,750 0 Sale to Issuer
    Nov 19, 2024 26,975 $385,743 0 Sale to Issuer
    President
    Nov 19, 2024 332,323 $0 640,191 (+51.9%) Grant
    President
    Nov 19, 2024 640,191 $9,154,731 0 Sale to Issuer
    Nov 19, 2024 26,975 $385,743 0 Sale to Issuer
    Nov 19, 2024 87,765 $1,255,040 0 Sale to Issuer
    Chief Executive Officer
    Nov 19, 2024 1,247,137 $0 1,604,819 (+77.7%) Grant
    Chief Executive Officer
    Nov 19, 2024 1,604,819 $22,948,912 0 Sale to Issuer
    Nov 19, 2024 49,522 $708,165 0 Sale to Issuer
    Chief Commercial Officer
    Nov 19, 2024 356,975 $5,104,743 0 Sale to Issuer
    Nov 19, 2024 53,748 $0 22,241 (-241.7%) Sale to Issuer
    Nov 19, 2024 56,962 $0 20,954 (-271.8%) Sale to Issuer
    Nov 19, 2024 20,594 $294,494 0 Sale to Issuer
    Principal Accounting Officer
    Officer
    Oct 1, 2024 324 $4,594 26,755 (-1.2%) Payment of Exercise Price